SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE-2. Total hours number 70 hours, including course 20 hours, seminars 50 hours.

Size: px
Start display at page:

Download "SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE-2. Total hours number 70 hours, including course 20 hours, seminars 50 hours."

Transcription

1 SYLLABUS ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE- Total hours number 70 hours, including course 0 hours, seminars 0 hours. Aim of the subject of Hematology: The study of etiology, pathogenesis, clinical manifestations, laboratory and instrumental options of patient examination axed on diagnosis of the diseases of hematopoietic system, to get hold of general principles of treatment and prophylaxis of this pathology. Basic content of the course: A. Lectures: No Topic Hours 1. Anemias. Definition. Classification of anemias. Iron deficiency anemia.. Megaloblastic anemias. Vitamin B1 deficiency anemia. Folate deficiency anemia. 3. Aplastic anemias. Metaplastic anemias. Renal anemias. Anemias of chronic disorders. 4. Hereditary and acquired hemolytic anemias.. Neoplastic disorders of hematopoietic system. Etiology. Pathogenesis. Acute leukemias. 6. Chronic myeloid leukemia. Idiopathic myelofibrosis. Polycythemia vera. 7. Plasma cell dyscrasias. Multiple myeloma. Chronic lymphocytic leukemia. 8. Malignant lymphomas. Classification. Pathogenesis. Hodgkin s lymphoma. Non-Hodgkin s lymphomas. 9. Disorders of primary hemostasis. Immune thrombocytopenias. Hereditary hemorrhagic teleangiectasia 10. Disorders of secondary hemostasis (coagulation). Hemophilia. Von Willebrand s disease. B. Seminars: Nr. Topic Hours 1. Anemias. Definition. Classification of anemias. Iron Deficiency Anemia. Definition. Incidence. Prevalence. Etiology. Pathogenesis. Definitions of iron deficiency states. Clinical manifestations, general symptoms. Fatigue and incidence of epithelial lesions in iron deficiency. Evolution and diagnosis. Laboratory findings. Plan of investigations in patients

2 with iron deficiency anemia. Differential diagnosis. Treatment. Prevention of relapse of iron deficiency anemia. Dispensary system.. Megaloblastic Anemias. Vitamin B1 Deficiency Anemia (Addison-Biermer Disease). Definition. Incidence. Etiology. Pathogenesis. Clinical manifestations. Evolution and diagnosis. Laboratory findings. Plan of investigations in patients with pernicious anemia. Diagnosis and differential diagnosis. Treatment. Reticulocyte response to treatment with vitamin B 1. Prognosis. Dispensary system. Folate Deficiency Anemia. Definition. Incidence. Etiology. Pathogenesis. Clinical manifestations, general symptoms. Laboratory findings. Diagnosis and differential diagnosis. Treatment of folate deficiency anemia. Prevention of relapse of anemia. Prognosis. Dispensary system. 3. Aplastic Anemia. Definition. Incidence. Etiology. Pathogenesis. Clinical manifestations, general symptoms. Laboratory findings. Diagnosis and differential diagnosis. Treatment. Prognosis. Dispensary system. Metaplastic Anemia. Definition. Etiology. Pathogenesis. Diseases associated with metaplastic anemia. Renal Anemia. Definition. Etiology. Pathogenesis. Anemias of Chronic Disorders. Etiology. Pathogenesis. Clinical manifestations. Laboratory findings. Diagnosis. Treatment. 4. Hemolytic Anemias: General considerations. Definition. Pathogenesis and classifications. Clinical and laboratory manifestations. Diagnostic approach to the patient. Diagnosis and differential diagnosis with bilirubinopathies (Gilbert s syndrome), biliary mecanical disease, biliary parenchima disease. Hereditary Hemolytic Disordes Affecting the Red Cell Membrane (Hereditary Spherocytosis, Hereditary Elliptocytosis, Hereditary Stomatocytosis, Hereditary Acanthocytosis). Clinical manifestations. Laboratory findings. Diagnosis and differential diagnosis. Treatment. Prevention of relapse of anemia. Prognosis. Dispensary system. Hereditary Hemolytic Disordes Affecting the Red Cell Enzymes. Glucose- 6-Phosphate Dehydrogenase deficiency and related deficiencies involving the Pentose Phosphate Pathway and Glutathione Metabolism, other enzyme deficiencies. Pathogenesis. Clinical manifestations. Laboratory findings. Diagnostic approach. Differential diagnosis. Treatment. Prognosis. Dispensary system. Hereditary Hemolytic Disorders Affecting Hemoglobin Structure and Synthesis (Hemoglobinopathies). The Thalassemias and Related Disorders - quantitative disorders of hemoglobin synthesis. Hemoglobinopathies S and the sickling syndromes (qualitative disorders). Prevalence and geographic distribution. Genetic mechanisms and molecular pathology. Clinical and laboratory features. Diagnosis and differential diagnosis. Treatment. Prognosis. Dispensary system. Acquired Hemolytic Anemias. Classification. Autoimmune hemolytic anemias. Etiology. Pathogenesis. Clinical manifestations. Laboratory findings. Diagnosis and differential diagnosis. Complications. Treatment. Prognosis. Dispensary system. Pure Red Cell Aplasia. Definition. Etiology. Pathogenesis. Clinical manifestations. Laboratory findings. Diagnosis and differential diagnosis. Treatment. Prognosis. Dispensary system. Paroxysmal Nocturnal Hemoglobinuria (Marchiafava-Micheli anemia).

3 Etiology and pathogenesis. Specific features of hemolytic syndrome. Clinical Treatment. Course and Prognosis. Dispensary system.. Neoplastic Disorders of the Hematopoietic System. Definition. Classification. Site of Origin in the Stem Cell Hierarchy. Etiology. Pathogenesis. Epidemiology. Incidence. Acute Leukemias. Definition. Morbidity. Pathogenesis. Classification. Clinical manifestations. Course, complications and causes of death; survival. Clinical difference between morphocytochemical variants. Diagnosis and differential diagnosis. Treatment. Prognosis. Dispensary system. 6. Chronic Leukemias. Definition. Classification. Chronic Myeloid Leukemia. Definition. Morbidity. Pathogenesis. Classification of chronic myeloid leukemia. Presenting features. Laboratory studies. Diagnosis and differential diagnosis. Course, complications and causes of death. Treatment. Prognosis. Dispensary system. Idiopathic Myelofibrosis. Definition. Morbidity. Pathogenesis. Clinical manifestations. Classification. Laboratory findings. Diagnosis and differential diagnosis. Complications and causes of death. Treatment. Prognosis. Dispensary system. Polycythemia Vera. Definition. Morbidity. Pathogenesis. Clinical manifestations. Blood and laboratory findings. Diagnosis and differential diagnosis. Complications. Treatment. Prognosis. Dispensary system. 7. Chronic Lymphocytic Leukemia. Definition. Morbidity. Pathogenesis. Clinical manifestations. Laboratory findings. Diagnosis and differential diagnosis. Complications and causes of death. Variants of chronic lymphocytic leukemia.treatment. Prognosis. Dispensary system. Plasma Cell Dyscrasias. General Considerations. Multiple Myeloma. Definition. Morbidity. Pathogenesis. Clinical Staging and prognosis. Treatment. Dispensary system. Waldenstrom Disease. Definition. Morbidity. Pathogenesis. Clinical Staging and prognosis. Treatment. Dispensary system. 8. Malignant Lymphomas. Definition. Classification. Hodgkin s Lymphoma. Morbidity. Etiology. Pathogenesis. Presenting features. Staging procedures. Diagnosis and differential diagnosis. Prognostic variability. Course of disease. Histological classification of Hodgkin s disiase. Clinical Staging for Hodgkin s disease (Ann Arbor Classification). Plan of investigations in patients with Hodgkin s Disease. Treatment. Prognosis. Dispensary system. Non-Hodgkin s Lymphomas. Morbidity. Etiology. Pathogenesis. Clinical manifestations Clinical staging. Diagnosis and differential diagnosis. Plan of investigations in patients with non-hodgkin s lymphomas. Histological classification. Treatment. Prognosis. Dispensary system. 9. Disorders of Hemostasis and Coagulation. Definition. Classification. Clinical manifestations. Diagnostic approach to the bleeding disorders. Clinical evaluation of the bleeding patients. Laboratory methods for the study of hemostasis and blood coagulation. Thrombocytopenic Purpura. Defin0ition. Morbidity. Etiology. Pathogenesis. Classification. Clinical manifestations. Laboratory findings. Diagnosis and differential diagnosis. Complications. Treatment. Prognosis. Hereditary Hemorrhagic Teleangiectasia (Rendu-Osler Disease).

4 Definition. Morbidity. Etiology. Pathogenesis. Clinical manifestations. Laboratory findings. Diagnosis and differential diagnosis. Treatment. Prognosis. 10. Hemophilia. Morbidity. Etiology. Principles of pathophysiology. Genetics. Incidence. Clinical manifestations. Course and prognosis. Laboratory diagnosis. Differential diagnosis. Treatment. Dental and surgery care. Prevention. Von Willebrand s Disease. Morbidity. Etiology. Pathogenesis. Clinical manifestations. Laboratory diagnosis. Differential diagnosis. Treatment. Prognosis. SUBJECT PLAN FOR THE STUDY ON HEMATOLOGY FOR THE 4-YEAR STUDENTS, MEDICINE- No. 1. Topic Anemias. Definition. Classification of anemias. Iron deficiency anemia. Number of hours lectures seminars. Vitamin B1 deficiency anemia. Folate deficiency anemia. 3. Aplastic anemias. Metaplastic anemias. Anemias of chronic disorders. Renal anemias. 4. Hereditary and acquired hemolytic anemias Neoplastic disorders of hematopoietic system: classifications, etiology, epidemiology, pathogenesis. Acute leukemias. Chronic myeloid leukemia. Idiopathic myelofibrosis. Polycythemia Vera. Chronic lymphocytic leukemia. Multiple myeloma. Waldenstrom Disease. Malignant lymphomas: Hodgkin s Lymphoma, non-hodgkin s Lymphomas. 9. Disorders of primary hemostasis. 10. Disorders of secondary hemostasis (coagulation). Recommended compulsory literature: Summary: 0 0

5 1. Course of Lectures on Hematology and Military Therapy by Musteata Vasile, Corcimaru Ion. Chisinau p.. American Society of Hematology Self-Assessment Program by Williams M.E., Kahn M.J. Blackwell Publishing: p. 3. The Washington Manual. Hematology and Oncology Subspecialty Consult by Pillot Giancarlo, Chantler Marcia, Magiera Holly et al. Lippincott, Williams & Wilkins: p.

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY 1. Module/unit Code II. 1.2. 2. Module/unit Title Hematology 3. Subject Field Internal Diseases Group 4. Faculty/Department General Medicine, Department of Hematology 5. Programme(s) to which the Doctor

More information

Contents SECTION 1: PHYSIOLOGY OF BLOOD

Contents SECTION 1: PHYSIOLOGY OF BLOOD Contents SECTION 1: PHYSIOLOGY OF BLOOD Chapter 1: Overview of Physiology of Blood 1 Normal Haematopoiesis 1 Red Blood Cells 6 White Blood Cells 15 Immune System 27 Megakaryopoiesis 32 Normal Haemostasis

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Acute lymphoblastic leukemia, in India, 439 440 pediatric, global approach to, 420 424 core resources in low- and middle-income countries, 423

More information

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization

12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,

More information

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam: Hematology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified hematologist

More information

Diagnostic Approach to Patients with Anemia

Diagnostic Approach to Patients with Anemia J KMA Special Issue Diagnostic Approach to Patients with Anemia Seonyang Park, MD Department of Internal Medicine, Seoul National University College of Medicine E mail : seonpark@snu.ac.kr J Korean Med

More information

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 July 3, 2013 The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 Re: Physician Compare Intelligent Search To Whom it May Concern, The American

More information

HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint

HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint HEMATOLOGY Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Hematology MOC exam blueprint Based on feedback from physicians that MOC assessments should

More information

The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011)

The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011) The Power of Peripheral Blood Smears: Apparent Diagnostic Clues (Part 1) (Wednesday, October 19, 2011) By Gene Gulati, Ph.D., SH(ASCP) Conflict of Interest None Plan for the Course Review blood smears,

More information

QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS

QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS WHAT IS TRUE AND WHAT IS FALSE? Questions 1 Iron deficiency anemia a) Is usually associated with a raised MCV. b) The MCH is usually low. c) Is most commonly due

More information

(anemia) ก hemoglobin concentration, hematocrit deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2

(anemia) ก hemoglobin concentration, hematocrit deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2 ก ก. ก ก.. ก (anemia) ก hemoglobin concentration, hematocrit ก ก ก 2 Standard deviation 1 1 ก hemoglobin, hematocrit mean corpuscular volume (MCV) 2 Hemoglobin hematocrit MCV (g/dl) (%) (fl) ( ) 0.5-1.9

More information

Preferred Clinical Services for Leading Age Florida August 26-27, 2015

Preferred Clinical Services for Leading Age Florida August 26-27, 2015 DIAGNOSIS CODING ESSENTIALS FOR LONG-TERM CARE: CHAPTER 3, D CODES DISEASES OF THE BLOOD AND BLOOD-FORMING ORGANS AND CERTAIN DISORDERS INVOLVING THE IMMUNE MECHANISM Preferred Clinical Services for Leading

More information

Disorders of Blood Cells & Blood Coagulation

Disorders of Blood Cells & Blood Coagulation Disorders of Blood Cells & Blood Coagulation HIHIM 409 WBC count RBC count WBC differential Hemoglobin (HGB) Hematocrit (HCT) % of volume occupied by RBCs CBC Red cell indices Mean cell volume (MCV) average

More information

Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009

Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009 HAEMOLYTIC ANAEMIA Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009 WHEN BY THEN Hb 9 g% transfusion

More information

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do? 101 May 17, 2014 Myelodysplastic Syndrome: Let s build a definition Myelo bone marrow Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine What is bone marrow? What does bone

More information

Examination Tests from Pathological Physiology. Pavel Maruna et al. Reviewed by: Prof. MUDr. Emanuel Nečas, DrSc. Prof. MUDr. Jaroslav Veselý, CSc.

Examination Tests from Pathological Physiology. Pavel Maruna et al. Reviewed by: Prof. MUDr. Emanuel Nečas, DrSc. Prof. MUDr. Jaroslav Veselý, CSc. Examination Tests from Pathological Physiology Pavel Maruna et al. Reviewed by: Prof. MUDr. Emanuel Nečas, DrSc. Prof. MUDr. Jaroslav Veselý, CSc. Authors: Prof. MUDr. Pavel Maruna, CSc. Doc. MUDr. Martin

More information

Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89

Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89 Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89 Presented by Jennifer Kurkulonis 1 FOUR MAJOR TYPES OF BLOOD CELLS White blood cells

More information

ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology

ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology ACGME approved: June 27, 2006; effective: July 1, 2007 ACGME approved focused revision: September 30, 2012; effective:

More information

Myelodysplastic Syndrome: Let s build a definition

Myelodysplastic Syndrome: Let s build a definition 1 MDS: Diagnosis and Treatment Update Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine Weill Medical College of Cornell University The New York Presbyterian Hospital Myelodysplastic

More information

Curriculum: Goals and Objectives Department of Medicine Harbor-UCLA Medical Center

Curriculum: Goals and Objectives Department of Medicine Harbor-UCLA Medical Center MEDICAL ONCOLOGY AND HEMATOLOGY (R2, R3) A. The PURPOSE of this rotation is to afford medical residents a broad clinical and training experience in the clinical diagnosis and management of common adult

More information

HEMATOLOGY MODULE STUDY GUIDE Course Title Hematology Module B Course Coordinator: Dr. Irfan Ashraf

HEMATOLOGY MODULE STUDY GUIDE Course Title Hematology Module B Course Coordinator: Dr. Irfan Ashraf HEMATOLOGY MODULE STUDY GUIDE A Course Title Hematology Module B Course Coordinator: Dr. Irfan Ashraf C Course Committee Dr. Irfan Ashraf, Dr. Syeda Zarreen Raza, Dr. Rubia Kashif D Objectives of Study

More information

11. An acute leukemia causing. 12. An adult patient presents with acute. 13. Anemia due to renal failure may be

11. An acute leukemia causing. 12. An adult patient presents with acute. 13. Anemia due to renal failure may be Hematology Study online at 1. A 23 year old white female has weakness, fatigue and has developed a habit of chewing ice. What are the expected findings in regard to TIBC and Ferritin? 2. A 25 year old

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Abdominal tumors, in children, 530 531 Alkalinization, in tumor lysis syndrome, 516 Allopurinol, in tumor lysis syndrome, 515 Anaphylaxis, drug

More information

SAUDI FELLOWSHIP TRAINING PROGRAM. Adult Haematology. Final Written Examination 2019

SAUDI FELLOWSHIP TRAINING PROGRAM. Adult Haematology. Final Written Examination 2019 SAUDI FELLOWSHIP TRAINING PROGRAM Adult Haematology Final Written Examination 2019 Examination Format: A. The Saudi fellowship specialty final written examination shall consist of one paper with 80-120

More information

78 The Power of Peripheral Blood Smears-Apparent Diagnostic Clues (Part 1) Gene Gulati PhD, SH(ASCP)

78 The Power of Peripheral Blood Smears-Apparent Diagnostic Clues (Part 1) Gene Gulati PhD, SH(ASCP) 78 The Power of Peripheral Blood Smears-Apparent Diagnostic Clues (Part 1) Gene Gulati PhD, SH(ASCP) 2011 Annual Meeting Las Vegas, NV AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 33 W. Monroe, Ste. 1600 Chicago,

More information

MDS: Who gets it and how is it diagnosed?

MDS: Who gets it and how is it diagnosed? MDS: Who gets it and how is it diagnosed? October 16, 2010 Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine Weill Medical College of Cornell University The New York Presbyterian

More information

Saudi Fellowship Training Program. Final Written Examination of Adult Hematology 2018

Saudi Fellowship Training Program. Final Written Examination of Adult Hematology 2018 Saudi Fellowship Training Program Final Written Examination of Adult Hematology 2018 Objectives: Determine the quantity and quality of a hematologist s knowledge base ranked as competent, so that the individual

More information

3/5/2013. Hematopoiesis: Red and white marrow. Hematopoiesis. Bone marrow aspirate and core biopsy. Gartner, Color Textbook of Histology, 3 rd Edition

3/5/2013. Hematopoiesis: Red and white marrow. Hematopoiesis. Bone marrow aspirate and core biopsy. Gartner, Color Textbook of Histology, 3 rd Edition Hematopoiesis Hematopoiesis: Red and white marrow Bone marrow aspirate and core biopsy Gartner, Color Textbook of Histology, 3 rd Edition 1 reticulocytes elliptocytes schistocytes spheroctyes target cells

More information

Approach to a pale child

Approach to a pale child Approach to a pale child Dr. Dafalla Ahmed Babiker Jazan university objectives Definition of anemia Classification and causes Important points in history and physical examination Investigations. Definition

More information

1. Adequate diet and iron intake to prevent iron deficiency 2. Signs and symptoms of malignant disease

1. Adequate diet and iron intake to prevent iron deficiency 2. Signs and symptoms of malignant disease Hematology/Oncology Description: The pediatric hematology-oncology division sees a wide spectrum of pediatric disease including but not limited to leukemia, hemophilia, solid tumors, ITP, and other blood

More information

HAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore

HAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore HAEMATOLOGICAL EVALUATION OF ANEMIA Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore Learning Objectives Laboratory tests for the evaluation of anemia

More information

Normal Development. Normal Development 10/16/2012. Hematopoietic and Lymph Node Pathology. Red Blood Cell Maturation & Anemias

Normal Development. Normal Development 10/16/2012. Hematopoietic and Lymph Node Pathology. Red Blood Cell Maturation & Anemias Hematopoietic and Lymph Node Pathology Normal Development Red Blood Cell Maturation & Anemias Normal Development Differentiation of Hematopoietic Cells 1 Bone Marrow Bone Marrow Bone Marrow, RBC Precursors

More information

Al-Balqa Applied University Faculty of Medicine

Al-Balqa Applied University Faculty of Medicine Al-Balqa Applied University Faculty of Medicine Course Title: Blood and Lymphatic System (BLS). Course Code: 31500371 Credit Hours: 4 Credits Calendar Description: 4 weeks/ sem.2/ year 2 Teaching approaches:

More information

THE UNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PATHOLOGY

THE UNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PATHOLOGY THE UNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PATHOLOGY INTRODUCTION TO ANEMIA Third year medical students First semester 2018/2019 Dr. RBC DISORDERS Lecturer: Dr. Tariq Al-Adaily Email: TNALADILY@ju.edu.jo

More information

Hematology/Oncology/BMT

Hematology/Oncology/BMT The University of Arizona Pediatric Residency Program Primary Goals for Rotation Hematology/Oncology/BMT 1. GOAL: Understand the role of the pediatrician in preventing hematologic or oncologic conditions,

More information

a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation

a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation a resource for physicians Recommended Referral Timing for Stem Cell Transplant Evaluation This resource has been developed to help guide you regarding the appropriate timing and conditions for a referral

More information

General Pathology Theory Syllabus for II B.D.S.

General Pathology Theory Syllabus for II B.D.S. General Pathology Theory Syllabus for II B.D.S. Sr. No. Topic (Must Know) (Desirable to know) 1.Introduction to Pathology - Different sections in pathology - The Cell in health - Normal cell structure

More information

Chapter 46. Care of the Patient with a Blood or Lymphatic Disorder

Chapter 46. Care of the Patient with a Blood or Lymphatic Disorder Chapter 46 Care of the Patient with a Blood or Lymphatic Disorder All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. Components of the Blood Red

More information

2013 Pathology Student

2013 Pathology Student About this guide If you re reading this introduction, it means you are probably either a) covering hematopathology in your pathology class right now, or b) studying for boards. Either way, you ve come

More information

Hematology Oncology Fellowship Self-Assessment of Knowledge Base and Skills

Hematology Oncology Fellowship Self-Assessment of Knowledge Base and Skills Hematology Oncology Fellowship Self-Assessment of Knowledge Base and Skills Name PGY Level Please assess your current understanding and skill level * for each of the topics below. Do not leave any areas

More information

The Evaluation and Classification of Anemia

The Evaluation and Classification of Anemia Case studies and research for better care To refer a patient, call. The Evaluation and Classification of Anemia A diagnostic approach BY AMANDA BRANDOW, DO, MS Anemia is defined as hemoglobin concentration

More information

2/13/2015. Hematopoiesis: Red and white marrow. Fluorescent in situ hybridization for chromosomal translocation. Hematopoiesis

2/13/2015. Hematopoiesis: Red and white marrow. Fluorescent in situ hybridization for chromosomal translocation. Hematopoiesis Fluorescent in situ hybridization for chromosomal translocation Hematopoiesis Hematopoiesis: Red and white marrow 1 Bone marrow aspirate and core biopsy Gartner, Color Textbook of Histology, 3 rd Edition

More information

Hematology Page 1 of 8

Hematology Page 1 of 8 Hematology Page 1 of 8 Hematology Major Category Code Headings Revised 12/17 1 Basic methodology and test armamentarium 20000 2 Normal hematopoiesis & hemostasis 20100 3 RBC disorders, non-neoplastic 20340

More information

Care of the Patient with a Blood or Lymphatic Disorder. ph Volume pints. Red blood cells (RBC) White blood cells (WBC)

Care of the Patient with a Blood or Lymphatic Disorder. ph Volume pints. Red blood cells (RBC) White blood cells (WBC) Slide 1 Chapter 7 Care of the Patient with a Blood or Lymphatic Disorder 1 Slide 1 Overview of Anatomy and Physiology Characteristics of blood Consistency (viscous) 45% blood cells RBC WBC Platelets 55%

More information

Course Outline. Course Title CLINICAL HEMATOLOGY. Prerequisite: MLT 112 or permission of instructor

Course Outline. Course Title CLINICAL HEMATOLOGY. Prerequisite: MLT 112 or permission of instructor Course Outline Course Number MLT 212 Course Title CLINICAL HEMATOLOGY Credits 4 Hours: Lecture 3/Lab 3 Prerequisite: MLT 112 or permission of instructor Spring 7A 2017 Catalog description: Examines hematology

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Anemia(s), 412 426 categories in morphologic approach to, macrocytic, 412 414 microcytic, 412 414 normocytic, 412 413 categorizing, 412

More information

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017 Anemia A case-based approach David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017 Recognizing trends Learning Objectives MCV, RDW, Ferritin, LDH, Reticulocytes Managing complex patients 1.

More information

C. treatment with Desferal (deferoxamine mesylate USP, iron-chelating agent)

C. treatment with Desferal (deferoxamine mesylate USP, iron-chelating agent) HEMOLYTIC ANEMIAS Single choice tests 1. Select the clinical manifestation that is not characteristic for the hemolytic crisis: A. decrease of the red blood cell count B. reticulocytosis C. jaundice D.

More information

Aplastic anamia & Sideroblastic anemia

Aplastic anamia & Sideroblastic anemia Hematology Lecture 7 كلية التقنيات الصحية والطبية قسم التحليالت المرضية Aplastic anamia & Sideroblastic anemia اإلعداد: ظفر جبار دهاق فؤاد APLASTIC ANEMIA What is Aplastic anemia? Aplastic anemia is a

More information

Clinical Symptoms of Blood System Affection: Anemia and Polycythemia; Leukopenias and Leukocytosis; Leukemia; Hemorrhagic Syndrome.

Clinical Symptoms of Blood System Affection: Anemia and Polycythemia; Leukopenias and Leukocytosis; Leukemia; Hemorrhagic Syndrome. Clinical Symptoms of Blood System Affection: Anemia and Polycythemia; Leukopenias and Leukocytosis; Leukemia; Hemorrhagic Syndrome. LECTURE IN INTERNAL MEDICINE PROPAEDEUTICS M. Yabluchansky, L. Bogun,

More information

Evaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC

Evaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC Evaluation of Anemia Md. Shafiqul Bari Associate professor (Medicine) SOMC Definition Anemia is operationally defined as a reduction in one or more of the major RBC measurements Hemoglobin concentration

More information

Pediatric Hematology-Oncology

Pediatric Hematology-Oncology Pediatric Hematology-Oncology Content Outline In-Training, Initial Certification, and Maintenance of Certification Exams Effective for exams administered beginning April 1, 2019 THE AMERICAN BOARD of PEDIATRICS

More information

HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE

HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE Log Out Help current login :lcytryn@montefiore.org HEMATOLOGIC MORPHOLOGY- AECOM HEMATOLOGY COURSE Lawrence Cytryn, M.D. - Course Director 1998 Edward Burns, M.D. Images used by permission within AECOM

More information

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi Anemia (3).ms4.25.Oct.15 Hemolytic Anemia Abdallah Abbadi Case 3 24 yr old female presented with anemia syndrome and jaundice. She was found to have splenomegaly. Hb 8, wbc 12k, Plt 212k, retics 12%, LDH

More information

Index. Note: Page numbers of article numbers are in boldface type.

Index. Note: Page numbers of article numbers are in boldface type. Index Note: Page numbers of article numbers are in boldface type. A Abdomen, acute, as cancer emergency, 381 399 in cancer patients, etiologies unique to, 390 392 in perforation, 388 surgery of, portal

More information

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College AN APPROACH TO BLEEDING DISORDERS NORMAL HEMOSTASIS After injury, 3 processes halt bleeding Vasoconstriction

More information

Anemia (3).ms Hemolytic Anemia. Abdallah Abbadi Feras Fararjeh

Anemia (3).ms Hemolytic Anemia. Abdallah Abbadi Feras Fararjeh Anemia (3).ms4.26.2.18 Hemolytic Anemia Abdallah Abbadi Feras Fararjeh Case 3 24 yr old female presented with anemia syndrome and jaundice. She was found to have splenomegaly. Hb 8, wbc 12k, Plt 212k,

More information

رناد زكريا Dr. ahmad Dr. ahmad. P a g e 1

رناد زكريا Dr. ahmad Dr. ahmad. P a g e 1 5 رناد زكريا Dr. ahmad Dr. ahmad P a g e 1 Before we start. -This sheet was written according to section 2 s record and reviewed according to section 1 s record by Ruba Hussien with all thanks and I referred

More information

General Characterisctics

General Characterisctics Anemia General Characterisctics Definition: anemia is a decrease in red blood cells. Happens due to underproduction, increased destruction or loss of red cells. Diagnosis of anemia: Hgb < 135 (men) Hgb

More information

Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017

Overview of Aplastic Anemia. Overview of Aplastic Anemia. Epidemiology of aplastic anemia. Normal hematopoiesis 10/6/2017 Overview of Aplastic Anemia Overview of Aplastic Anemia Peter Westervelt, MD, PhD Professor of Medicine Chief, BMT/Leukemia Section Washington University School of Medicine Epidemiology Normal hematopoiesis

More information

University: Alexandria Faculty : Medicine Program Specifications (Academic year: 2015)

University: Alexandria Faculty : Medicine Program Specifications (Academic year: 2015) الهيئة القومية لضمان جودة التعليم واالعتماد University: Alexandria Faculty : Medicine Program Specifications (Academic year: 2015) الهيئة القومية لضمان جودة التعليم واالعتماد A. Basic Information: 1. Program

More information

Strict Covered Limitations that may be used by some ASO groups. covered in full for Men only, age 65-75

Strict Covered Limitations that may be used by some ASO groups. covered in full for Men only, age 65-75 1 2 3 4 5 Recommendation Adult Aortic Aneurysm Screening (one time age 65-75 if ever smoked) Alcohol & Drug Misuse Screening and Behavioral Counseling Intervention Aspirin for the Prevention of Cardiovascular

More information

The function of the bone marrow. Living with Aplastic Anemia. A Case Study - I. Hypocellular bone marrow failure 5/14/2018

The function of the bone marrow. Living with Aplastic Anemia. A Case Study - I. Hypocellular bone marrow failure 5/14/2018 The function of the bone marrow Larry D. Cripe, MD Indiana University Simon Cancer Center Bone Marrow Stem Cells Mature into Blood Cells Mature Blood Cells and Health Type Function Term Red Cells Carry

More information

A. Definitions... CD-114. B. General Information... CD-116

A. Definitions... CD-114. B. General Information... CD-116 CD Part 7 Blood Diseases A. Definitions... CD-114 B. General Information... CD-116 C. Specific Listings and Residual Functional Capacity... CD-117 1. Listing 7.02: Chronic Anemia (Adults)... CD-117 2.

More information

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias Hematology and Hematologic Malignancies Cancer of the formed elements of the blood What is a hematological malignancy? A hematologic malignancy is a malignancy (or cancer) of any of the formed elements

More information

Tim R. Randolph. PhD, MT(ASCP) Chair and Associate Professor Department of Biomedical Laboratory Science Saint Louis University

Tim R. Randolph. PhD, MT(ASCP) Chair and Associate Professor Department of Biomedical Laboratory Science Saint Louis University Tim R. Randolph. PhD, MT(ASCP) Chair and Associate Professor Department of Biomedical Laboratory Science Saint Louis University Anemias Over 30 types Myeloproliferative Neoplasm Polycythemia Leukemia AML:M6

More information

Introduction and Approach to Anemia

Introduction and Approach to Anemia 2 nd lecture in Hematology by Dr.Alaa Fadhil Alwan Introduction and Approach to Anemia Anemia is defined clinically as a blood hemoglobin or hematocrit value that is below the appropriate reference range

More information

THE CLASSIFICATION OF ANEMIA*

THE CLASSIFICATION OF ANEMIA* THE CLASSIFICATION OF ANEMIA* RUSSELL L. HADEN, M.D. SUMMARY A laboratory and clinical classification of anemia has been outlined. The results of the blood study have been correlated with the clinical

More information

Myeloproliferative Disorders in the Elderly: Clinical Presentation and Role of Bone Marrow Examination

Myeloproliferative Disorders in the Elderly: Clinical Presentation and Role of Bone Marrow Examination Myeloproliferative Disorders in the Elderly: Clinical Presentation and Role of Bone Marrow Examination Arati V. Rao, M.D. Division of Medical Oncology and Geriatrics Duke University Medical Center Durham

More information

Theme: Making Further Advancements in the Treatment of Hematologic Diseases - Frontline therapies and future prospects -

Theme: Making Further Advancements in the Treatment of Hematologic Diseases - Frontline therapies and future prospects - Theme: Making Further Advancements in the Treatment of Hematologic Diseases - Frontline therapies and future prospects - Professor Yutaka YATOMI, M.D., Ph.D., The Department of Clinical Laboratory Medicine,

More information

Blood Transfusion Guidelines in Clinical Practice

Blood Transfusion Guidelines in Clinical Practice Blood Transfusion Guidelines in Clinical Practice Salwa Hindawi Director of Blood Transfusion Services Associate Professor in Haematology and Transfusion Medicine King Abdalaziz University, Jeddah Saudi

More information

Chapter 13 The Blood

Chapter 13 The Blood Chapter 13 The Blood Copyright 2015 Wolters Kluwer Health Lippincott Williams & Wilkins Overview Key Terms agglutination erythrocyte lymphocyte albumin fibrin megakaryocyte anemia hematocrit monocyte antigen

More information

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU Coagulation Disorders Dr. Muhammad Shamim Assistant Professor, BMU 1 Introduction Local Vs. General Hematoma & Joint bleed Coagulation Skin/Mucosal Petechiae & Purpura PLT wound / surgical bleeding Immediate

More information

Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology

Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology Faculty representative: Neil Weiner, MD Resident representative: Guiherme Rabinowits, MD Revision date: February 28, 2006 Goals

More information

Hematologic changes in systemic diseases. Chittima Sirijerachai

Hematologic changes in systemic diseases. Chittima Sirijerachai Hematologic changes in systemic diseases Chittima Sirijerachai Systemic diseases Infection Renal diseases Liver diseases Connective tissue diseases Malignancy Anemia of chronic disease (ACD) Chronic infections:

More information

Acute Comorbidity Categories

Acute Comorbidity Categories ESRD PPS Comorbidity Categories and Diagnosis Codes Crosswalk Gastrointestinal Bleeding 530.21 Ulcer of esophagus with bleeding 531.00 Acute gastric ulcer with, without mention of Acute Comorbidity Categories

More information

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY HEMATOCRIT Hematocrit is a measure of the percentage of the total blood volume that is made up by the red blood cells The hematocrit can be determined directly

More information

Recommended Timing for Transplant Consultation

Recommended Timing for Transplant Consultation REFERRAL GUIDELINES Recommended Timing for Transplant Consultation Published jointly by the National Marrow Donor Program /Be The Match and the American Society for Blood and Marrow Transplantation BeTheMatchClinical.org

More information

Lec.2 Medical Physiology Blood Physiology Z.H.Kamil

Lec.2 Medical Physiology Blood Physiology Z.H.Kamil Destruction of Red Blood Cells When red blood cells are delivered from the bone marrow into the circulatory system, they normally circulate an average of 120 days before being destroyed. Even though mature

More information

2 Principles of Blood Collection...

2 Principles of Blood Collection... Preface iv PART ONE: The Principles of Hematology 1 Safety and Quality in the Hematology Laboratory..... 1 An Overview of the Hematology Laboratory 1 The Study of Hematology 1 Functions of the Hematology

More information

1) Anemias Dr. Anwar Sheikha

1) Anemias Dr. Anwar Sheikha 1) Anemias Dr. Anwar Sheikha DEFINITION: Anemia can be defined as a reduction in the concentration of hemoglobin below what is normal for age and sex of the patient. This reduction of hemoglobin is usually

More information

Anemia In the Insurance Applicant What do the numbers mean?

Anemia In the Insurance Applicant What do the numbers mean? Anemia In the Insurance Applicant What do the numbers mean? Lisa Duckett, M.D. Vice President and Medical Director September 12, 2017 Goals of the presentation Develop a consistent way to analyze Complete

More information

Deconstructing the CBC

Deconstructing the CBC Deconstructing the CBC Dr. Ann M. Wexler Solano Hematology Oncology September 10, 2017 What Are the Major Components of Blood? Red Blood Cells (also called erythrocytes) White Blood Cells (also called

More information

Clinical implications for decreased lymphocytes (lymphopenia) o Corticosteroid therapy, adrenocortical hyperfunction, stress, shock

Clinical implications for decreased lymphocytes (lymphopenia) o Corticosteroid therapy, adrenocortical hyperfunction, stress, shock Learning Objectives At the completion of this program, the participants will be able to: 1. Identify the components of the CBC and Differential and their clinical implications. 2. Identify normal pediatric

More information

STUDY GUIDE. At the end of the module, the students should be able to: Outcomes

STUDY GUIDE. At the end of the module, the students should be able to: Outcomes Module Title Introduction Hematology STUDY GUIDE This Hematology module hinges on the previous Blood module taught in semester 2. This module will focus on the abnormal aspects of Blood. It will deal with

More information

FBC CASES Vernon Louw Clinical Haematology 2010

FBC CASES Vernon Louw Clinical Haematology 2010 FBC CASES Vernon Louw Clinical Haematology 2010 FOR EACH OF THE FOLLOWING PATIENTS, SELECT THE MOST LIKELY FINDING FROM THE ANALYSIS OF THE PERIPHERAL BLOOD. A patient with infectious mononucleosis. A

More information

Hematologic Disorders. Assistant professor of anesthesia

Hematologic Disorders. Assistant professor of anesthesia Preoperative Evaluation Hematologic Disorders Dr M.Razavi Assistant professor of anesthesia Anemia Evaluation needs to consider the extent and type of surgery, the anticipated blood loss, and the patient's

More information

Blood Cancers. Blood Cells. Blood Cancers: Progress and Promise. Bone Marrow and Blood. Lymph Nodes and Spleen

Blood Cancers. Blood Cells. Blood Cancers: Progress and Promise. Bone Marrow and Blood. Lymph Nodes and Spleen Blood Cancers: Progress and Promise Mike Barnett & Khaled Ramadan Division of Hematology Department of Medicine Providence Health Care & UBC Blood Cancers Significant health problem Arise from normal cells

More information

The Child with a Hematologic Alteration

The Child with a Hematologic Alteration 47 The Child with a Hematologic Alteration HELPFUL HINT Review the anatomy and physiology of the hematologic system in an anatomy and physiology textbook. MATCHING KEY TERMS Match the term with the correct

More information

What are the four parts of blood and what are their main functions?

What are the four parts of blood and what are their main functions? 1/24/19 Bell Ringer: Please COPY THE QUESTION in your notebook and date it below your drawing from yesterday: THEN ANSWER IT IN WRITING IN YOUR NOTEBOOK FOR POINTS. What are the four parts of blood and

More information

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA Introduction: GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS These guidelines have been developed in conjunction with the hospital Transfusion Committee.

More information

HAEMATOLOGICAL MALIGNANCY

HAEMATOLOGICAL MALIGNANCY HAEMATOLOGICAL MALIGNANCY Reference Compulsory reading Haematology at Glance 2 nd ed. Atul Mehta & Victor Hoffbrand Chapters: 20 to 31 Pages: 46 to 69 Pathogenesis of Haematological Malignancy Figure (a)

More information

PCCN Review Hematology

PCCN Review Hematology PCCN Review Hematology Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC CEN, CNRN, CMSRN, NP Education Specialist LRM Consulting Nashville, TN Anemia Definition reduction in RBC concentration Causes iron deficiency

More information

The American Society of Hematology (ASH) represents more than 17,000 clinicians and

The American Society of Hematology (ASH) represents more than 17,000 clinicians and American Society of Hematology Statement to the House Appropriations Subcommittee on Labor, HHS, Education, and Related Agencies FY 2020 Funding for NIH and CDC The American Society of Hematology (ASH)

More information

PROBLEMS OF THE HEMATOLOGICAL SYSTEM

PROBLEMS OF THE HEMATOLOGICAL SYSTEM PROBLEMS OF THE HEMATOLOGICAL SYSTEM UNIT 5 Review A & P of Hematological system Outline focused exam Differentiate and start to evaluate diagnostic exams used to assess problems of the hematological system

More information

STUDY GUIDE. At the end of the module, students should be able to:

STUDY GUIDE. At the end of the module, students should be able to: Module Title Introduction STUDY GUIDE Hematology This Hematology module hinges on the previous Blood module taught in semester 2. This module will focus on the abnormal aspects of Blood. It will deal with

More information

REVIEW OF THE HEMATOPOIETIC SYSTEM

REVIEW OF THE HEMATOPOIETIC SYSTEM REVIEW OF THE HEMATOPOIETIC SYSTEM BLOOD BLOOD = Plasma + Formed Elements PLASMA = 91% Water + 7-8% Proteins + 1-2% small molecules SERUM = Plasma Clotting Factors PLASMA PROTEINS Together, the plasma

More information

Blood Components & Indications for Transfusion. Neda Kalhor

Blood Components & Indications for Transfusion. Neda Kalhor Blood Components & Indications for Transfusion Neda Kalhor Blood products Cellular Components: Red blood cells - Leukocyte-reduced RBCs - Washed RBCs - Irradiated RBCs Platelets - Random-donor platelets

More information

Year 2003 Paper two: Questions supplied by Tricia

Year 2003 Paper two: Questions supplied by Tricia QUESTION 65 A 36-year-old man presents in a post-ictal state after an observed generalised seizure. Full blood investigation shows: haemoglobin 0 g/l [128-175] mean corpuscular volume (MCV) 106 fl [80-7]

More information